Personalized Deep Brain Stimulation Shows Promise for Improving Walking in Parkinson's Disease
核心洞察
UCSF researchers developed a personalized approach to deep brain stimulation (搜索) (DBS) that significantly improves walking ability in Parkinson's disease (搜索) patients by customizing brain stimulation settings based on individual gait patterns and brain activity.
The team created a Walking Performance Index (WPI) that comprehensively measures factors like step length, walking speed, and arm swing, providing a reliable tool for assessing and targeting gait improvements in Parkinson's patients.
Machine learning analysis identified specific brain activity patterns in the globus pallidus (搜索) region linked to better walking, particularly decreased beta frequency signals during walking cycles.
Researchers at the University of California-San Francisco (搜索) (UCSF) have developed a breakthrough personalized approach to deep brain stimulation (搜索) (DBS) that significantly improves walking ability in people with Parkinson's disease (搜索), addressing one of the most disabling symptoms of this progressive neurological disorder.
The study, published in npj Parkinson's Disease (搜索), represents a major advance in treating "Parkinson's gait," which affects patients' ability to walk normally and increases their fall risk while reducing mobility and quality of life.
Novel Engineering Approach to Brain Stimulation
The UCSF team treated DBS optimization as an engineering challenge, developing a method to measure walking performance in detail and using machine learning to discover optimal brain stimulation settings for each individual patient. This personalized approach led to meaningful improvements in patients' walking, including quicker and more stable steps, without worsening other Parkinson's symptoms.
"This work not only deepens our understanding of how DBS affects movement but also highlights the promise of personalized neuromodulation for Parkinson's and other neurological disorders, bringing us closer to smarter more effective neuromodulation therapies," said Dr. Doris Wang, senior researcher and associate professor of neurological surgery at UCSF.
Walking Performance Index Development
During the study, three Parkinson's patients were implanted with specialized DBS devices capable of both stimulating the brain and recording brain activity while walking. At clinic visits, researchers adjusted each patient's DBS settings while patients walked repeatedly around a six-meter loop, with sensors capturing detailed movement and brain activity data.
The team developed a comprehensive Walking Performance Index (WPI) that measured factors such as step length, stride speed, and arm swing. This index provided a well-rounded assessment of walking quality, with results matching closely with both clinician and patient evaluations of walking ability.
"Our results confirmed that changes in DBS settings were effectively captured by the WPI, aligning with patient and clinician evaluations during each visit," said lead researcher Hamid Fekri Azgomi, a postdoctoral scholar at UCSF. "This validation supports that the WPI is an effective metric for assessing and targeting gait improvements in people with Parkinson's."
Brain Activity Pattern Discovery
The research identified specific brain activity patterns linked to improved walking performance, particularly in the globus pallidus (搜索), a brain region associated with movement control that is often affected in Parkinson's disease (搜索). The team found that when certain brain signals, especially those in the beta frequency range, decreased during specific moments in the walking cycle, patients demonstrated smoother movement patterns.
"Using these techniques, we were able to predict and identify personalized DBS settings that improved the WPI," Azgomi explained.
Clinical Impact and Future Directions
While DBS has proven highly effective in treating tremors, rigidity, and slow movement in Parkinson's patients, its impact on gait has historically been less reliable. This new personalized approach addresses that limitation by tailoring stimulation parameters to each patient's unique brain activity and walking patterns.
The research team plans to develop automated systems capable of capturing gait patterns in real-time and feeding data into DBS programming software, using the WPI to make more accurate adjustments. Future developments may include wearable devices and motion-tracking technology that enable continuous monitoring and precise DBS optimization outside clinical settings.
Parkinson's disease (搜索) affects movement when brain cells that produce dopamine die or become impaired, leading to progressive symptoms including shaking, stiffness, and balance problems. The personalized DBS approach represents a significant step toward more targeted, data-driven treatments for this challenging neurological condition.